Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovic Lacroix

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
NPJ Precision Oncology|September 23, 2020
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave RoussyGonzalo Recondo, Linda Mahjoubi, Aline Maillard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
Plos Medicine|December 28, 2016
Mutational Profile of Metastatic Breast Cancers: A Retrospective AnalysisCeline Lefebvre, Thomas Bachelot, Thomas Filleron, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
NPJ Precision Oncology|November 25, 2025
Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patientsCristina Smolenschi, Saumya D Sisoudiya, Antoine Hollebecque, et al.
Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway InhibitorsNaoual Menssouri, Loïc Poiraudeau, Carole Helissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2020
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non-Small Cell Lung CancerSandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
NPJ Precision Oncology|September 23, 2020
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave RoussyGonzalo Recondo, Linda Mahjoubi, Aline Maillard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
BMC Cancer|July 24, 2013
SISH/CISH or qPCR as alternative techniques to FISH for determination of HER2 amplification status on breast tumors core needle biopsies: a multicenter experience based on 840 casesJocelyne Jacquemier, Frédérique Spyratos, Benjamin Esterni, et al.
Plos Medicine|December 28, 2016
Mutational Profile of Metastatic Breast Cancers: A Retrospective AnalysisCeline Lefebvre, Thomas Bachelot, Thomas Filleron, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
NPJ Precision Oncology|November 25, 2025
Comprehensive molecular landscape of anal squamous cell carcinoma: analysis of tissue and liquid biopsies from 1844 patientsCristina Smolenschi, Saumya D Sisoudiya, Antoine Hollebecque, et al.
Communications Biology|September 18, 2023
A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumorsMaria Eugénia Marques Da Costa, Sakina Zaidi, Jean-Yves Scoazec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway InhibitorsNaoual Menssouri, Loïc Poiraudeau, Carole Helissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2020
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non-Small Cell Lung CancerSandra Ortiz-Cuaran, Laura Mezquita, Aurélie Swalduz, et al.
Pageof 18